Facility and Resources

The University of Nebraska Medical Center (UNMC) and its affiliated hospital, Nebraska Medicine, comprise the Medical Center campus which is located in central Omaha, Nebraska. Over 300 new cases of hematologic malignancy, as well as numerous benign disorders, are reviewed for the regional Nebraska Leukemia/Lymphoma Study Group each year. Most of these cases are handled according to a special protocol for obtaining tissue for immunologic, molecular and cytogenetic studies at the various contributing institutions, and then the tissues are shipped to UNMC for evaluation and classification. A detailed computerized clinical database is collected and maintained on each case for research purposes and all reports and representative slides are kept on each case in the Study Group Registry. Over 1,100 new patients per year, and over 23,000 total patients, are enrolled in the Registry. Approximately, 2,700 biopsies of lymph nodes and other tissues with hematologic disorders are reviewed each year, with 54,000 total biopsies in the registry. An active bone marrow and peripheral blood stem cell transplantation program at UNMC (150 cases per year) provides additional interesting material for study. Approximately 1,200 bone marrow specimens from UNMC are examined yearly, in addition to outside consultations (400 per year).